» Articles » PMID: 35600462

Case Report: Treatment Planning Study to Demonstrate Feasibility of Transthoracic Ultrasound Guidance to Facilitate Ventricular Tachycardia Ablation With Protons

Abstract

Background: Cardiac arrhythmias, such as ventricular tachycardia, are disruptions in the normal cardiac function that originate from problems in the electrical conduction of signals inside the heart. Recently, a non-invasive treatment option based on external photon or proton beam irradiation has been used to ablate the arrhythmogenic structures. Especially in proton therapy, based on its steep dose gradient, it is crucial to monitor the motion of the heart in order to ensure that the radiation dose is delivered to the correct location. Transthoracic ultrasound imaging has the potential to provide guidance during this treatment delivery. However, it has to be noted that the presence of an ultrasound probe on the chest of the patient introduces constraints on usable beam angles for both protons and photon treatments. This case report investigates the possibility to generate a clinically acceptable proton treatment plan while the ultrasound probe is present on the chest of the patient.

Case: A treatment plan study was performed based on a 4D cardiac-gated computed tomography scan of a 55 year-old male patient suffering from refractory ventricular tachycardia who underwent cardiac radioablation. A proton therapy treatment plan was generated for the actual treatment target in presence of an ultrasound probe on the chest of this patient. The clinical acceptability of the generated plan was confirmed by evaluating standard target dose-volume metrics, dose to organs-at-risk and target dose conformity and homogeneity.

Conclusion: The generation of a clinically acceptable proton therapy treatment plan for cardiac radioablation of ventricular tachycardia could be performed in the presence of an ultrasound probe on the chest of the patient. These results establish a basis and justification for continued research and product development for ultrasound-guided cardiac radioablation.

Citing Articles

Cardiorespiratory-gated cardiac proton radiotherapy using a novel ultrasound guidance system.

Cengel K, Belal Z, Kim M, Hagan S, Camps S, Kalinin A Clin Transl Radiat Oncol. 2025; 51:100904.

PMID: 39867728 PMC: 11764844. DOI: 10.1016/j.ctro.2024.100904.


Radiation therapy for ventricular arrhythmias.

Liulu X, Balaji P, Barber J, De Silva K, Murray T, Hickey A J Med Imaging Radiat Oncol. 2024; 68(8):893-913.

PMID: 38698577 PMC: 11686466. DOI: 10.1111/1754-9485.13662.


Analysis of left ventricle regional myocardial motion for cardiac radioablation: Left ventricular motion analysis.

Poon J, Thompson R, Deyell M, Schellenberg D, Clark H, Reinsberg S J Appl Clin Med Phys. 2024; 25(5):e14333.

PMID: 38493500 PMC: 11087184. DOI: 10.1002/acm2.14333.


Deep learning-based ultrasound transducer induced CT metal artifact reduction using generative adversarial networks for ultrasound-guided cardiac radioablation.

Puvanasunthararajah S, Camps S, Wille M, Fontanarosa D Phys Eng Sci Med. 2023; 46(4):1399-1410.

PMID: 37548887 PMC: 10703740. DOI: 10.1007/s13246-023-01307-7.


Combined clustered scan-based metal artifact reduction algorithm (CCS-MAR) for ultrasound-guided cardiac radioablation.

Puvanasunthararajah S, Camps S, Wille M, Fontanarosa D Phys Eng Sci Med. 2022; 45(4):1273-1287.

PMID: 36352318 PMC: 9747859. DOI: 10.1007/s13246-022-01192-6.

References
1.
Camps S, Fontanarosa D, de With P, Verhaegen F, Vanneste B . The Use of Ultrasound Imaging in the External Beam Radiotherapy Workflow of Prostate Cancer Patients. Biomed Res Int. 2018; 2018:7569590. PMC: 5829356. DOI: 10.1155/2018/7569590. View

2.
Prusator M, Samson P, Cammin J, Robinson C, Cuculich P, Knutson N . Evaluation of Motion Compensation Methods for Noninvasive Cardiac Radioablation of Ventricular Tachycardia. Int J Radiat Oncol Biol Phys. 2021; 111(4):1023-1032. DOI: 10.1016/j.ijrobp.2021.06.035. View

3.
Poon J, Kohli K, Deyell M, Schellenberg D, Reinsberg S, Teke T . Technical Note: Cardiac synchronized volumetric modulated arc therapy for stereotactic arrhythmia radioablation - Proof of principle. Med Phys. 2020; 47(8):3567-3572. DOI: 10.1002/mp.14237. View

4.
Rossi S . The National Centre for Oncological Hadrontherapy (CNAO): Status and perspectives. Phys Med. 2015; 31(4):333-51. DOI: 10.1016/j.ejmp.2015.03.001. View

5.
Videtic G, Hu C, Singh A, Chang J, Parker W, Olivier K . A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2015; 93(4):757-64. PMC: 4744654. DOI: 10.1016/j.ijrobp.2015.07.2260. View